BuMA® Biodegradable-Drug-Coating Coronary Stent System

A coronary stent system without drug coating used to mechanically support narrowed coronary arteries and restore blood flow. Suitable for short-term revascularization in acute coronary syndromes.

A coronary stent coated with antiproliferative medication to reduce restenosis rates following percutaneous coronary intervention. Provides sustained drug delivery to the vessel wall over extended periods.

A coronary stent system designed to deliver therapeutic agents directly to arterial lesions, reducing restenosis rates in percutaneous coronary intervention procedures. Manufactured in Vietnam with proven clinical efficacy and biocompatibility.

Advanced stent platform with pharmaceutical coating for coronary applications. Reduces restenosis risk while maintaining vessel patency in patients with coronary artery disease.

MiStent® is a sirolimus-eluting coronary stent with absorbable polymer coating designed for percutaneous coronary intervention. The cobalt chromium alloy structure provides sustained radial support and fatigue resistance for treating coronary artery stenosis. The drug-eluting mechanism reduces neointimal proliferation while the absorbable polymer eliminates chronic inflammatory response after healing.

Drug-eluting and bare metal stent platforms for coronary artery disease treatment and acute coronary syndrome management.

Compound stent combining polypropylene and superelastic shape-memory alloy that delivers structural stability and adaptive fit within native coronary anatomy.

Innovative cardiac stent designed to degrade completely within two years post-implantation, eliminating long-term foreign material presence in coronary vessels.

Peripheral drug-eluting stent for arterial disease treatment, delivering sirolimus to prevent restenosis in peripheral vasculature.

Advanced drug-eluting stent coatings that deliver pharmaceutical agents with controlled release profiles to prevent vessel restenosis. These specialty coatings combine hydrophilic polymers with active drug compounds, applied to stent surfaces to enhance biocompatibility and clinical efficacy in cardiovascular interventions.

A biodegradable stent manufactured from synthesized polymers with controlled composition and molecular weight. The stent is designed for high-strength performance and is absorbed by the body after placement.

Drug-eluting stent platforms that combine mechanical support with pharmaceutical delivery mechanisms for vascular applications. The product line includes multiple proprietary formulations and coating technologies.